Recombinant DNA Advisory Committee - 3/3-4/94 
Paul Kleinman, Biopharmaceutical Writers Service 
Lx)ri Kobayashi, Hood College 
Steven Kradjian, Vical, Inc. 
Richard Lazar, Cell Genesys 
Timothy Lestingi, University of Chicago 
Irene Lowe, Scipress News Bureau 
Stephen Lupton, Targeted Genetics Corporation 
Tamie Malaska, Targeted Genetics Corporation 
Tony Marcel, TMC Development 
Michael McCaughan, The Pink Sheet 
Brian McGuire, Cell Genesys 
Janice McTeague, Genzyme Corporation 
Bruce Merchant, Viagene, Inc. 
James Merritt, Viagene, Inc. 
Andra Miller, Food and Drug Administration 
Michael Nash, M. D. Anderson Cancer Center 
Jim Neidhart, University of New Mexico 
Krista Nowell, Flood College 
Sheryl Osborne, Viagene, Inc. 
Robert Overell, Targeted Genetics Corporation 
Lalida Panpradit, Hood College 
Anne Petruska, The Blue Sheet 
Lisa Piercey, BioWorld 
Stephen Pijar, University of Maryland 
Dennis Piszkiewicz, Baxter Healthcare Corporation 
Chris Platsoucas, Temple University 
Raj Puri, Food and Drug Administration 
Urban Ramstedt, Virus Research Institute 
Judy Randal, The Economist 
Janet Ransom, Organon Teknika Corporation 
Paul Recer, Associated Press 
Rex Rhein, Biotechnology Newswatch 
Margo Roberts, Cell Genesys, Inc. 
Joseph Rosenblatt, University of California, Los Angeles 
Jack Roth, M. D. Anderson Cancer Center 
Patricia Ryan, Genetic Therapy, Inc. 
Masahiko Sato, Taisho University 
Bruce Schackman, CIT Group 
Hans Schreier, Vanderbilt University 
Robert Seeger, Children's Hospital of Los Angeles 
G. Terry Sharrer, National Museum of American History 
Sharon Smith, Hood College 
Lisa Song, Hood College 
Arlene Stecenko, Vanderbilt University 
Margi Stuart, Prevention Research Center 
Frank Sturtz, Progenitor, Inc. 
Recombinant DNA Research, Volume 19 
[15] 
